Epilepsy has been found to reduce the generation of new neurons
News May 12, 2015
International research is exploring the potential of neural stem cells in future therapies to fight the disease
Amanda Sierra and Juan Manuel Encinas, Ikerbasque researchers at the Achucarro centre (Achucarro Basque Center for Neuroscience) have discovered a new property of hippocampal neural stem cells by using an epilepsy model in genetically modified mice. The work has been published in the Cell Stem Cell journal, the main international reference in stem cell research.
The mission of neural stem cells located in the hippocampus, one of the main regions of the brain, is to generate new neurons during the adult life of mammals, including human beings, of course, and their function is to participate in certain types of learning and responses to anxiety and stress. Using an epilepsy model in genetically modified mice, the researchers have discovered that hippocampal neural stem cells stop generating new neurons and are turned into reactive astrocytes, a cell type that promotes inflammation and alters communication between neurons.
This research work has also made it possible to confirm the hypothesis in a previous piece of research by these researchers; this hypothesis established that even though neuronal hyperexcitation does not go as far as to cause convulsions, it does induce the massive activation of neural stem cells and their resulting premature exhaustion; as a result, neurogenesis (generation of new neurons) in the hippocampus ends up chronically reduced.
Juan Manuel Encinas, who is leading the study, highlights the fact that "this discovery has enabled us to gain a better understanding about how neural stem cells function. We have shown that in addition to generating neurons and astrocytes, neural stem cells in the adult hippocampus can generate reactive astrocytes following an epileptic seizure".
Even though the work has been carried out on experimental animals, this discovery has clear implications in clinical practice and in the quest for new therapies for epilepsy given that the generation of new neurons (neurogenesis) is a process that is negatively affected in epileptic seizures located in the hippocampus. "If we can manage to preserve the population of neural stem cells and their capacity to generate new neurons in humans, it may be possible to prevent the development of certain symptoms associated with epilepsy and very likely to mitigate the damage that is caused in the hippocampus," pointed out Juan Manuel Encinas.
In this ambitious, multidisciplinary project they have collaborated with research groups attached to institutions such as the Baylor College of Medicine in Houston (United States), the Université Catholique de Louvain (Belgium), the Achucarro centre itself, and the UPV/EHU's Genetic Expression Service.
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Amanda Sierra, Soraya Martín-Suárez, Roberto Valcárcel-Martín, Jesús Pascual-Brazo, Sarah-Ann Aelvoet, Oihane Abiega, Juan J. Deudero, Amy L. Brewster, Irantzu Bernales, Anne E. Anderson, Veerle Baekelandt, Mirjana Maletic-Savatic, Juan M. Encinas. Neuronal Hyperactivity Accelerates Depletion of Neural Stem Cells and Impairs Hippocampal Neurogenesis. Cell Stem Cell, Published May 7 2015. doi: 10.1016/j.stem.2015.04.003
Synaptotagmin 7 Ensures Efficiency of Inhibitory Signal TransmissionNews
Researchers at IST Austria define function of an enigmatic synaptic protein, synaptotagmin 7.READ MORE
Molecules in Spit Could Help Diagnose ConcussionsNews
Diagnosing a concussion can sometimes be a guessing game, but clues taken from small molecules in saliva may be able to help diagnose and predict the duration of concussions in children, according to Penn State College of Medicine researchers.READ MORE
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell TypesNews
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.READ MORE